Exact Sciences reports third-quarter revenue growth of 85 percent to $219 million
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Exact Sciences (EXAS) Tops Q3 EPS by 10c, FY Revenue Guidance Misses at Mid-Point
October 29, 2019 4:11 PM EDTExact Sciences (NASDAQ: EXAS) reported Q3 EPS of ($0.31), $0.10 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $218.8 million versus the consensus estimate of $216.11 million.
GUIDANCE:
Exact Sciences sees FY2019 revenue of $802-810 million, versus the consensus of... More
